Skip to main content

Nexalin Technology Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Devices

Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin’s products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects. The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil, and Oman.

Did you know?

Holds 654783.0x more cash than debt — a strong balance sheet.

Current Price

$0.38

+0.03%

GoodMoat Value

$0.08

79.4% overvalued
Profile
Valuation (TTM)
Market Cap$7.10M
P/E-0.86
EV
P/B1.89
Shares Out18.65M
P/Sales23.52
Revenue$301647.00
EV/EBITDA

Nexalin Technology Inc (NXL) Social Sentiment

NXL Social Sentiment Analysis

Social media sentiment analysis for Nexalin Technology Inc (NXL). Track bullish and bearish sentiment, mention volume, and BuzzScore trends from StockTwits and Reddit. Social sentiment provides a crowd-sourced view of investor confidence in NXL.

Current stock price: $0.38. Market cap: $7.10M. This page displays sentiment timelines, bullish vs bearish ratios, total mention counts, peak BuzzScore data, and source breakdowns for NXL. The sentiment data is updated regularly to reflect the latest social media activity.

Social sentiment is one of many signals to consider when evaluating a stock. High bullish sentiment combined with strong fundamentals may reinforce a buy thesis. Use GoodMoat's sentiment tracking alongside quality analysis, financial data, and valuation models to make well-informed investment decisions about Nexalin Technology Inc.